Trader consensus on Polymarket reflects an 84.5% implied probability for no new WHO-designated COVID-19 variant of concern (VOC) before 2027, driven by sustained population immunity from vaccines and prior infections that continue to blunt severe outcomes from emerging strains. The recent BA.3.2 "Cicada" subvariant, an Omicron descendant detected in over 30 U.S. states and 30 countries since late March 2026, has sparked monitoring as a Variant Under Monitoring due to its mutations and faster spread, but lacks evidence of heightened severity or widespread hospitalizations—test positivity remains low at around 2%. No VOC has been declared since Omicron in 2021, underscoring high barriers like robust hybrid immunity; a dramatic surge in cases or deaths would be needed to shift odds.